TWO SIGMA ADVISERS, LP - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 215 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.10 and the average weighting 0.2%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,162,277
+61.0%
409,700
+31.5%
0.03%
+61.1%
Q2 2023$6,933,100
+1700.8%
311,600
+2019.7%
0.02%
+1700.0%
Q4 2020$385,000
-40.9%
14,700
-60.7%
0.00%
-50.0%
Q3 2020$651,000
-69.6%
37,400
-70.6%
0.00%
-66.7%
Q2 2020$2,143,000
+394.9%
127,400
+250.0%
0.01%
+200.0%
Q1 2020$433,000
+131.6%
36,400
+175.8%
0.00%
Q3 2019$187,000
+52.0%
13,200
+20.0%
0.00%
Q2 2019$123,000
-66.5%
11,000
-64.9%
0.00%
-100.0%
Q1 2019$367,000
+8.6%
31,303
+23.7%
0.00%0.0%
Q4 2018$338,000
-84.1%
25,303
-80.4%
0.00%
-83.3%
Q1 2018$2,120,000
-47.6%
128,894
-42.5%
0.01%
-45.5%
Q4 2017$4,049,000
-28.2%
224,194
-23.3%
0.01%
-31.2%
Q3 2017$5,641,000
+192.7%
292,294
+79.0%
0.02%
+166.7%
Q2 2017$1,927,000
-18.7%
163,294
-24.5%
0.01%
-25.0%
Q1 2017$2,371,000
+18.2%
216,294
-21.7%
0.01%0.0%
Q4 2016$2,006,000
+97.6%
276,300
+77.0%
0.01%
+100.0%
Q3 2016$1,015,000
+23.9%
156,087
+4.0%
0.00%0.0%
Q2 2016$819,000
+6.8%
150,087
-8.5%
0.00%0.0%
Q1 2016$767,000
-14.5%
163,987
-9.0%
0.00%
-20.0%
Q4 2015$897,000
+17.1%
180,178
-6.9%
0.01%0.0%
Q3 2015$766,000
+136.4%
193,598
+258.6%
0.01%
+150.0%
Q2 2015$324,00053,9870.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Consonance Capital Management LP 5,188,417$85,349,0007.80%
TANAKA CAPITAL MANAGEMENT INC 144,602$2,379,0005.69%
INGALLS & SNYDER LLC 6,817,540$112,149,0005.47%
NEXTHERA CAPITAL LP 1,045,196$17,193,0002.83%
Timpani Capital Management LLC 245,279$4,035,0001.41%
S&T BANK/PA 426,257$7,012,0001.25%
SHAKER INVESTMENTS LLC/OH 107,670$1,771,0001.10%
ESSEX INVESTMENT MANAGEMENT CO LLC 434,624$7,150,0000.94%
AMI ASSET MANAGEMENT CORP 709,300$11,668,0000.83%
Birchview Capital, LP 75,500$1,242,0000.82%
View complete list of CORCEPT THERAPEUTICS INC shareholders